Pfizer Ducks Lipitor Fraud Claims Suit Again In 2nd Circ.
The Second Circuit will not rethink its decision to uphold the dismissal of a former Pfizer medical director's suit claiming the company helped defraud the federal government after marketing cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article